User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential.

  • Open access
  • PDF
  • 2.05 M
  1. Davies Louise, Welch H. Gilbert, Increasing Incidence of Thyroid Cancer in the United States, 1973-2002, 10.1001/jama.295.18.2164
  2. Belgian Cancer Registry data available at http://www.kankerregister.org/media/docs/StK_publicatie.pdf , accessed on the 7th of September, 2011.
  3. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. SEER Cancer Statistics Review, 1975–2002. Bethesda, MD: National Cancer Institute; 2004.
  4. Baloch Zubair W., LiVolsi Virginia A., Follicular-Patterned Lesions of the Thyroid : The Bane of the Pathologist, 10.1309/8vl9-ecxy-nvmx-2rqf
  5. Liu Zhiyan, Zhou Gengyin, Nakamura Misa, Koike Eisuke, Li Yaqiong, Ozaki Takashi, Mori Ichiro, Taniguchi Emiko, Kakudo Kennichi, Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal, 10.1111/j.1349-7006.2010.01769.x
  6. Williams E. Dillwyn, , Guest Editorial: Two Proposals Regarding the Terminology of Thyroid Tumors, 10.1177/106689690000800304
  7. Arora Nimmi, Scognamiglio Theresa, Lubitz Carrie C., Moo Tracy A., Kato Meredith A., Zhu Baixin, Zarnegar Rasa, Chen Yao-Tseng, Fahey Thomas J., Identification of borderline thyroid tumors by gene expression array analysis, 10.1002/cncr.24616
  8. Fusco Alfredo, Chiappetta Gennaro, Hui Pei, Garcia-Rostan Ginesa, Golden Lauren, Kinder Barbara K., Dillon Deborah A., Giuliano Ada, Cirafici Anna Maria, Santoro Massimo, Rosai Juan, Tallini Giovanni, Assessment of RET/PTC Oncogene Activation and Clonality in Thyroid Nodules with Incomplete Morphological Evidence of Papillary Carcinoma, 10.1016/s0002-9440(10)61164-9
  9. de Matos P S, Ferreira A P, de Oliveira Facuri F, Assumpcao L V M, Metze K, Ward L S, Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy, 10.1111/j.1365-2559.2005.02221.x
  10. Papotti Mauro, Rodriguez Jaime, Pompa Roberta De, Bartolazzi Armando, Rosai Juan, Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential, 10.1038/modpathol.3800321
  11. Saiz Antonio D., Olvera Maria, Rezk Sherif, Florentine Barbara A., McCourty Althea, Brynes Russell K., Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions, 10.1002/path.1185
  12. Pujani M, Arora B, Pujani M, Singh SK, Tejwani N, Role of Ki-67 as a proliferative marker in lesions of thyroid, 10.4103/0019-509x.64727
  13. Wang Songtao, Lloyd Ricardo V., Hutzler Michael J., Safran Marjorie S., Patwardhan Nilima A., Khan Ashraf, The Role of Cell Cycle Regulatory Protein, Cyclin D1, in the Progression of Thyroid Cancer, 10.1038/modpathol.3880157
  14. Sheyn I, Noffsinger A.E, Heffelfinger S, Davis B, Miller M.A, Fenoglio-Preiser C.M, Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas, 10.1016/s0046-8177(97)90123-4
  15. Perisanidis Christos, Perisanidis Beata, Wrba Fritz, Brandstetter Anita, El Gazzar Sabine, Papadogeorgakis Nikolaos, Seemann Rudolf, Ewers Rolf, Kyzas Panayiotis A., Filipits Martin, Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma : p53, p21, p27, cyclin D1, and Ki67 in OOSCC, 10.1111/j.1600-0714.2011.01071.x
  16. DeLellis RA, LIoyd RV, Heitz PU, Eng C, World Health Organization Classification of Tumours. Pathology and genetics of tumours of Endocrine Organs. Lyon: IARC press; 2004.
  17. LiVolsi Virginia A., Pure versus follicular variant of papillary thyroid carcinoma : Clinical features, prognostic factors, treatment, and survival, 10.1002/cncr.11750
  18. Tan Ayca, Etit Demet, Bayol Umit, Altinel Deniz, Tan Sedat, Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high–molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma, 10.1016/j.anndiagpath.2010.11.005
  19. GraphPad Software, La Jolla California USA, www.graphpad.com
  20. Nasr Michel R, Mukhopadhyay Sanjay, Zhang Shengle, Katzenstein Anna-Luise A, Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: utility of HBME1 combined with CK19 immunostaining, 10.1038/modpathol.3800705
  21. Pennelli N, Pennelli G, Merante Boschin I, Pelizzo MR. Thyroid intrafollicular neoplasia (TIN) as a precursor of papillary microcarcinoma. Ann Ital Chir. 2005;76:219–24.
  22. Jares P, Fernández PL, Campo E. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res. 1994;54:4813–7.
  23. Piana Simonetta, Frasoldati Andrea, Di Felice Enza, Gardini Giorgio, Tallini Giovanni, Rosai Juan, Encapsulated Well-differentiated Follicular-patterned Thyroid Carcinomas Do Not Play a Significant Role in the Fatality Rates From Thyroid Carcinoma : , 10.1097/pas.0b013e3181dbee07
Bibliographic reference Lamba Saini, Monika ; Weynand, Birgit ; Rahier, Jacques ; Mourad, Michel ; Hamoir, Marc ; et. al. Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential.. In: Diagnostic Pathology, Vol. 10, no. 1, p. 32 [1-9] (2015)
Permanent URL http://hdl.handle.net/2078.1/158567